Summary
The authors have studied the levels of 5-HT and 5-HIA,—in serum, CSP fluid and pericardial fluid of cadavers at the Forensic Anatomic Institute of Granada and its relations with the length of agonic suffering. The results showed us that the study of 5-HT and its main metabolite, the 5-HIAA, may be useful for the exact evaluation of agonic suffering, and the pericardial fluid is most suited for the analysis of 5-HT and 5-HIAA.
We found that there was a significant correlation between the 5-HT and 5-HIAA and the agonic suffering. When the agonic sufferings of a moderate length (10 min-6h) were compared with the slow and long processes of death, the correlation was highly significant (P<0.001).
Zusammenfassung
Wir haben die 5-Hydroxy-tryptamin- und 5-Hydroxyindol-Essigsäure-Werte im Serum, in der Cerebrospinalflüssigkeit und in der Perikard-Flüssigkeit aus gerichtlichen Leichen, die im Anatomischen Institut für Rechtsmedizin in Granada obduziert wurden, und den Zusammenhang mit der Dauer der Agonie untersucht. Die Ergebnisse erlauben uns zu behaupten, daß die Bestimmung des 5-Hydroxy-tryptamin und seines wichtigen Metabolits, der 5-Hydroxy-indol-Essigsäure, große Möglichkeiten für die genaue Bewertung der Agonie eröffnet. Ideal ist die Bestimmung in der Perikard-Flüssigkeit.
Similar content being viewed by others
Literatur
Berg S (1966) Postmortem blood chemistry in the diagnosis. Microfilm 3:9
Berg S, Ditt J (1969) El contenido en histamina de la sangre cadavérica en las muertes violentas. Zacchia 5:569–572
Buckpit AP, Maickel R, Talmage B (1978) Pulmonary disposition of serotonin in the intact animal. Biochemical Pharmacology 27:569–574
Castellanos M, Villanueva E (1980a) Cambios iónicos en la agonia. Zacchia 16:173–179
Castellanos M, Villanueva E (1980b) Estudio de los iones metálicos en el suero postmortem en relación con la causa de la muerte, la edad y el sexo. Zacchia 16:296–305
Eliakis EC (1974) Que peut-on attendre de la recherche des 17-cetosteroides pour le diagnostic medico legal de l'agonie en cas de comourance. Actes Con Int Med Legal Social (Liège) 1:529–534
Fekete JF, Kerenyi NA (1965) Postmortem blood sugar of and blood urea, nitrogen determinations. Can Med Assoc J 92:970–973
Fozard JR, Mwaluko GMP (1976) Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Br J Pharmacol 57:115–125
Gisbert-Calabuig JA (1977) Medicina Legal y Toxicologia. Saber, Valencia
Goodman L, Gilman A (1975) Bases farmacológicas de la terapeutica. Nueva edn. 5a. ed. Interamericana, Méjico, pp 515–518, 520
Grubb M, Burks T (1974) Modification of intestinal stimulatory effects of 5-hydroxytryptamine by adrenergic amines, prostaglandin E1 and theophylline. J Pharmacol Exp Ther 189:476–483
Ichikawa A, Kaneko H, Mori Y, Tomita K (1977) Release of serotonin from mast cells induced by N-(2-ethylhexyl)-3-hydroxybutyramide and catecholamine. Biochem Pharmacol 26:197–202
Laves WC (1966) Agonia. Med M W 4:260–269
Laves WC, Berg S (1965) Agonie. Physiologisch-chemische Untersuchungen bei gewaltsamen Todesarten. Schmidt-Römhild, Lübeck, S 112–113 und 119
Maling HM, Webster MA, Wilford W, Anderson W (1974) Inflammation induced by histamine, serotonin, bradikinin and compound 48/80 in the rat: Antagonists and mechanisms of action. J Pharmacol Exp Ther 191:300–310
Merrill GF, Kline RL, Haddy FJ, Grega GJ (1974) Effects of locally infused serotonin oiv canine forelimb weight and segmental vascular resistances. J Pharmacol Exp Ther 189:140–148
Morau et al (1974) The study of blood cholinesterase in the cadaver in various kinds of death. Proceeding of the Third International Meeting in Forensic Immunology Medicine, Pathology and Toxycology
Olsson R, Ross BE (1968) Concentrations of 5-hydroxyindoleacetic acid and homovanilic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature 219:502–503
Pickett RD, Anderson MW, Orton TC, Eling TE (1975) The pharmacodynamics of 5-H-T-uptake and metabolism by the isolated perfused rabbit lung. J Pharmacol Exp Ther 194:545–553
Sampath SS, Neff NH (1974) The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus. J Pharmacol Exp Ther 188:410–414
Tablas Cientificas Geigy (1975) 7a edn. Geigy, Barcelona, pp 586–648
Tamarkin NR, Goodwin FK, Axelrod J (1970) Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci (Part I, Physiol Pharmacol) 9:1397–1408
Toda N (1975) Analysis of the effect of 5-hydroxykynurenamine, a serotonin metabolite, on isolated cerebral arteries, Aortas and atria. J Pharmacol Exp Ther 193:385–392
Tonge JI, Wannan JS (1969) The post-mortem blood sugar. Med J Aust 1:439–447
Udenfriend S (1962) Fluorescence assay in biology and medicine, vol 1. Academic Press, New York, pp 171–172
VanPraag HM, Korf J, Dols LCW, Schmit T (1972) A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan on antidepressants. Psychopharmacologia 25:14–21
Vidrio H, Hong E (1976) Vascular tone and reactivity to serotonin in the internal and external carotid vascular beds of the dog. J Pharmacol Exp Ther 197:49–56
Weissbach H (1966) In: Seligson D (ed) Métodos seleccionados de analisis clinicos, vol IV. Academic Press, Aguilar, Madrid, pp 157–162
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luna, A., Villanueva, E., Hernandez-Cueto, C. et al. Verhalten des 5-Hydroxy-tryptamin und der 5-Hydroxyindol-Essigsäure im Zusammenhang mit der Agonie (I.). Z Rechtsmed 89, 215–226 (1983). https://doi.org/10.1007/BF00203725
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00203725
Key words
- Agonic suffering, 5-Hydroxy tryptamin, 5-Hydroxy-indol acid
- 5-Hydroxy tryptamin, agonic suffering
- 5-Hydroxy-indol acid, agonic suffering